Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3093

Actual shortage: 246 (8%)
Anticipated shortage: 15 (0%)
Avoided shortage: 9 (0%)
Resolved: 2823 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CANDESARTAN 32MG TABLET Resolved 2017-03-20 2020-02-25 3516
APO-CANDESARTAN 32MG TABLET Resolved 2020-05-13 2020-09-21 114928
APO-CANDESARTAN 32MG TABLET Actual shortage 2021-10-22 2021-10-22 147815
APO-CANDESARTAN 32MG TABLET Actual shortage 2022-03-11 2022-03-11 156534
APO-RISEDRONATE 35MG TABLET Resolved 2017-03-11 2017-05-02 598
APO-RISEDRONATE 35MG TABLET Resolved 2018-08-21 2018-10-19 58626
APO-RISEDRONATE 35MG TABLET Resolved 2018-10-19 2018-12-21 64981
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-11-04 95874
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2020-10-07 2020-12-29 125809
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2020-12-11 2021-01-20 130040
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2021-03-26 2021-04-12 136409
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2021-06-11 2021-07-26 140777
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2021-12-03 2021-12-20 150432
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2022-11-04 2022-12-09 173823
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2024-02-09 2024-03-08 219141
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2024-04-26 2024-06-14 226309
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-10 2017-04-01 384
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-08-31 16942
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-10 28553
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-06-04 37966

Showing 1961 to 1980 of 3093

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HYDROCHLOROTHIAZIDE Discontinued 2019-11-26 2019-11-26 99653
APO-IMIQUIMOD Discontinued 2019-11-26 2019-11-26 99672
APO-CARBAMAZEPINE Discontinued 2020-02-19 2020-02-19 106679
APO-CLONAZEPAM .5MG TABLET Discontinued 2018-09-07 2018-09-15 60402
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-DICLOFENAC OPHTHALMIC 0.1% SOLUTION Discontinued 2018-09-07 2019-02-13 60426
APO-BRIMONIDINE 0.2% SOLUTION To be discontinued 2018-09-07 2018-09-07 60294
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2018-09-07 2018-12-28 60301
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40947
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Discontinued 2019-01-04 2019-01-04 71189
APO-TIMOP 0.5% SOLUTION Discontinued 2019-01-03 2019-01-03 70894
APO-LORAZEPAM 0.5MG TABLET Discontinued 2018-09-07 2018-12-28 60591
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-BROMAZEPAM 1.5MG TABLET To be discontinued 2018-09-07 2018-09-07 60304
APO-OLANZAPINE 10.0MG TABLET Discontinued 2018-09-08 2018-12-18 60672

Showing 41 to 60 of 356